Steve Schonfeld’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3M | Sell |
7,764
-76,113
| -91% | -$28.2M | 0.01% | 864 |
|
|
2026
Q1 | $24.6M | Buy |
83,877
+81,532
| +3,477% | +$26.8M | 0.17% | 111 |
|
|
2025
Q4 | $822K | Sell |
2,345
-19,535
| -89% | -$6.6M | ﹤0.01% | 1202 |
|
|
2025
Q3 | $7.07M | Buy |
21,880
+20,778
| +1,885% | +$6.46M | 0.04% | 458 |
|
|
2025
Q2 | $429K | Sell |
1,102
-1,098
| -50% | -$442K | ﹤0.01% | 1597 |
|
|
2025
Q1 | $957K | Sell |
2,200
-848
| -28% | -$340K | 0.01% | 1319 |
|
|
2024
Q4 | $1.12M | Sell |
3,048
-15,528
| -84% | -$6.5M | 0.01% | 1067 |
|
|
2024
Q3 | $9.66M | Buy |
18,576
+11,776
| +173% | +$6.29M | 0.06% | 308 |
|
|
2024
Q2 | $3.68M | Sell |
6,800
-26,196
| -79% | -$13.8M | 0.02% | 659 |
|
|
2024
Q1 | $17.1M | Sell |
32,996
-9,361
| -22% | -$4.66M | 0.11% | 211 |
|
|
2023
Q4 | $20M | Sell |
42,357
-35,082
| -45% | -$16.2M | 0.13% | 163 |
|
|
2023
Q3 | $33.7M | Buy |
77,439
+22,905
| +42% | +$10.4M | 0.26% | 73 |
|
|
2023
Q2 | $24.2M | Buy |
54,534
+39,034
| +252% | +$18M | 0.21% | 145 |
|
|
2023
Q1 | $7.13M | Sell |
15,500
-27,381
| -64% | -$13M | 0.07% | 358 |
|
|
2022
Q4 | $22M | Sell |
42,881
-61,584
| -59% | -$31.3M | 0.18% | 146 |
|
|
2022
Q3 | $47.5M | Buy |
104,465
+31,965
| +44% | +$15.3M | 0.4% | 35 |
|
|
2022
Q2 | $35M | Buy |
72,500
+33,100
| +84% | +$16.4M | 0.34% | 50 |
|
|
2022
Q1 | $19.4M | Sell |
39,400
-4,064
| -9% | -$1.86M | 0.17% | 127 |
|
|
2021
Q4 | $20.1M | Buy |
+43,464
| New | +$18.3M | 0.18% | 134 |
|
|
2021
Q2 | – | Sell |
-3,441
| Closed | -$1.24M | – | 2034 |
|
|
2021
Q1 | $1.24M | Buy |
+3,441
| New | +$1.11M | 0.02% | 814 |
|
|
2020
Q3 | – | Sell |
-10,455
| Closed | -$2.75M | – | 1426 |
|
|
2020
Q2 | $2.75M | Buy |
10,455
+7,838
| +300% | +$2.09M | 0.07% | 339 |
|
|
2020
Q1 | $594K | Buy |
2,617
+714
| +38% | +$195K | 0.04% | 526 |
|
|
2019
Q4 | $575K | Sell |
1,903
-9,238
| -83% | -$2.54M | 0.01% | 692 |
|
|
2019
Q3 | $2.67M | Buy |
11,141
+4,141
| +59% | +$1.13M | 0.08% | 260 |
|
|
2019
Q2 | $1.98M | Sell |
7,000
-36,600
| -84% | -$10M | 0.07% | 290 |
|
|
2019
Q1 | $12.5M | Buy |
43,600
+31,000
| +246% | +$8.97M | 0.43% | 48 |
|
|
2018
Q4 | $3.31M | Buy |
12,600
+100
| +0.8% | +$27.5K | 0.13% | 224 |
|
|
2018
Q3 | $3.43M | Sell |
12,500
-26,320
| -68% | -$6.83M | 0.15% | 191 |
|
|
2018
Q2 | $9.24M | Buy |
38,820
+11,050
| +40% | +$2.56M | 0.5% | 32 |
|
|
2018
Q1 | $6.1M | Sell |
27,770
-7,667
| -22% | -$1.8M | 0.46% | 45 |
|
|
2017
Q4 | $7.97M | Buy |
+35,437
| New | +$7.55M | 0.65% | 21 |
|
|
2017
Q3 | – | Sell |
-4,787
| Closed | -$900K | – | 646 |
|
|
2017
Q2 | $900K | Buy |
+4,787
| New | +$860K | 0.09% | 295 |
|
Other funds holding ELV
Steve Schonfeld's ELV Position: Q2 2026 in Review
Steve Schonfeld reduced its Elevance Health (ELV) stake by 91% in Q2 2026, selling an estimated $28.2M and leaving 7,764 shares worth $3M. The position accounts for 0.01% of the portfolio, ranked #864.
Steve Schonfeld first reported a position in ELV in Q2 2017 and has held it in 32 quarters since. The position peaked at $47.5M in Q3 2022. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Steve Schonfeld held 7,764 shares of Elevance Health worth $3M as of Q2 2026.
- Steve Schonfeld sold 76,113 Elevance Health shares in Q2 2026, an estimated $28.2M.
- Elevance Health made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #864 holding.
- Steve Schonfeld first reported a position in Elevance Health in Q2 2017 and has held it in 32 quarters since.
- Steve Schonfeld's Elevance Health position peaked at $47.5M in Q3 2022.
- 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.